Hommes DW - Search Results

1

Efficacy of recombinant granulocyte colony-stimulating factor (rhG-CSF) in experimental colitis.

Hommes DW, Meenan J, Dijkhuizen S, Ten Kate FJ, Tytgat GN, Van Deventer SJ. Hommes DW, et al. Clin Exp Immunol. 1996 Dec;106(3):529-33. doi: 10.1046/j.1365-2249.1996.d01-863.x. Clin Exp Immunol. 1996. PMID: 8973623 Free PMC article.

2

Attenuation of the inflammatory response in an animal colitis model by neutrophil inhibitory factor, a novel beta 2-integrin antagonist.

Meenan J, Hommes DW, Mevissen M, Dijkhuizen S, Soule H, Moyle M, Büller HR, ten Kate FW, Tytgat GN, van Deventer SJ. Meenan J, et al. Among authors: hommes dw. Scand J Gastroenterol. 1996 Aug;31(8):786-91. doi: 10.3109/00365529609010353. Scand J Gastroenterol. 1996. PMID: 8858748

3

Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammation.

Hommes DW, Meenan J, de Haas M, ten Kate FJ, von dem Borne AE, Tytgat GN, van Deventer SJ. Hommes DW, et al. Gut. 1996 Apr;38(4):564-7. doi: 10.1136/gut.38.4.564. Gut. 1996. PMID: 8707088 Free PMC article.

4

Lexipafant (BB-882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis.

Meenan J, Grool TA, Hommes DW, Dijkhuizen S, ten Kate FJ, Wood M, Whittaker M, Tytgat GN, van Deventer SJ. Meenan J, et al. Among authors: hommes dw. Eur J Gastroenterol Hepatol. 1996 Jun;8(6):569-73. doi: 10.1097/00042737-199606000-00014. Eur J Gastroenterol Hepatol. 1996. PMID: 8823572

5

Anti- and proinflammatory cytokines in the pathogenesis of tissue damage in Crohn's disease.

Hommes DW, van Deventer SJ. Hommes DW, et al. Curr Opin Clin Nutr Metab Care. 2000 May;3(3):191-5. doi: 10.1097/00075197-200005000-00005. Curr Opin Clin Nutr Metab Care. 2000. PMID: 10871234 Review.

6

Production and cellular source of interleukin-8 in ulcerative colitis.

Hommes DW, Radema SA, Jansen J, Smit F, Fockens P, Zhao Y, Ceska M, Tytgat GN, van Deventer SJ. Hommes DW, et al. Inflamm Bowel Dis. 1995 Summer;1(2):108-16. Inflamm Bowel Dis. 1995. PMID: 23282303

7

Modulation of cytokine release from human monocytes by drugs used in the therapy of inflammatory bowel diseases.

Bruin KF, Hommes DW, Jansen J, Tytgat GN, Wouter ten Cate J, van Deventer SJ. Bruin KF, et al. Among authors: hommes dw. Eur J Gastroenterol Hepatol. 1995 Aug;7(8):791-5. Eur J Gastroenterol Hepatol. 1995. PMID: 7496871

8

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

van Dullemen HM, van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Tytgat GN, Woody J. van Dullemen HM, et al. Among authors: hommes dw. Gastroenterology. 1995 Jul;109(1):129-35. doi: 10.1016/0016-5085(95)90277-5. Gastroenterology. 1995. PMID: 7797011 Clinical Trial.

9

Specific inhibition of c-Raf activity by semapimod induces clinical remission in severe Crohn's disease.

Löwenberg M, Verhaar A, van den Blink B, ten Kate F, van Deventer S, Peppelenbosch M, Hommes D. Löwenberg M, et al. J Immunol. 2005 Aug 15;175(4):2293-300. doi: 10.4049/jimmunol.175.4.2293. J Immunol. 2005. PMID: 16081798

10

Endoscopy in inflammatory bowel diseases.

Hommes DW, van Deventer SJ. Hommes DW, et al. Gastroenterology. 2004 May;126(6):1561-73. doi: 10.1053/j.gastro.2004.03.023. Gastroenterology. 2004. PMID: 15168367 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

254 results

Search Page

Filters